Добірка наукової літератури з теми "Sar/spr"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Sar/spr".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "Sar/spr"
Dudek, F. Edward. "Selective Inhibitory Interneuron Loss Produces Chronic Hippocampal Hyperexcitability." Epilepsy Currents 2, no. 1 (January 2002): 21–22. http://dx.doi.org/10.1111/j.1535-7597.2002.00007.x.
Повний текст джерелаRice, Amy J., Russell P. Pesavento, Jinhong Ren, Isoo Youn, Youngjin Kwon, Kassapa Ellepola, Chun-Tao Che, Michael E. Johnson, and Hyun Lee. "Identification of Small Molecule Inhibitors against Staphylococcus aureus Dihydroorotase via HTS." International Journal of Molecular Sciences 22, no. 18 (September 15, 2021): 9984. http://dx.doi.org/10.3390/ijms22189984.
Повний текст джерелаHuang, Johnny X., Mohammad A. K. Azad, Elizabeth Yuriev, Mark A. Baker, Roger L. Nation, Jian Li, Matthew A. Cooper та Tony Velkov. "Molecular Characterization of Lipopolysaccharide Binding to Humanα-1-Acid Glycoprotein". Journal of Lipids 2012 (2012): 1–15. http://dx.doi.org/10.1155/2012/475153.
Повний текст джерелаFreidel, Matthew R., Pratiti A. Vakhariya, Shalinder K. Sardarni, and Roger S. Armen. "The Dual-Targeted Fusion Inhibitor Clofazimine Binds to the S2 Segment of the SARS-CoV-2 Spike Protein." Viruses 16, no. 4 (April 20, 2024): 640. http://dx.doi.org/10.3390/v16040640.
Повний текст джерелаGarcía Marín, Javier. "Deciphering the inhibition mechanism of a pseudokinase: integrin-bound kinase and cpd22." Anales de la Real Academia Nacional de Farmacia 88, no. 88(02) (June 30, 2022): 131–48. http://dx.doi.org/10.53519/analesranf.2022.88.02.03.
Повний текст джерелаSizochenko, Natalia, and Jerzy Leszczynski. "Review of Current and Emerging Approaches for Quantitative Nanostructure-Activity Relationship Modeling." Journal of Nanotoxicology and Nanomedicine 1, no. 1 (January 2016): 1–16. http://dx.doi.org/10.4018/jnn.2016010101.
Повний текст джерелаGerner, Ingrid, Gabriele Graetschel, Jürgen Kahl, and Eva Schlede. "Development of a Decision Support System for the Introduction of Alternative Methods into Local Irritancy/Corrosivity Testing Strategies. Development of a Relational Database." Alternatives to Laboratory Animals 28, no. 1 (January 2000): 11–28. http://dx.doi.org/10.1177/026119290002800106.
Повний текст джерелаScala, Maria Carmina, Mariangela Agamennone, Agostina Pietrantoni, Veronica Di Sarno, Alessia Bertamino, Fabiana Superti, Pietro Campiglia, and Marina Sala. "Discovery of a Novel Tetrapeptide against Influenza A Virus: Rational Design, Synthesis, Bioactivity Evaluation and Computational Studies." Pharmaceuticals 14, no. 10 (September 23, 2021): 959. http://dx.doi.org/10.3390/ph14100959.
Повний текст джерелаJi, Xingyue. "Prodrug Strategies for Critical Drug Developability Issues: Part I." Current Topics in Medicinal Chemistry 21, no. 24 (September 2021): 2155–56. http://dx.doi.org/10.2174/156802662124211104100228.
Повний текст джерелаMahapatra, Dheeren Ku, and Lakshi Prosad Roy. "Empirical model for SAR ground clutter data." IET Signal Processing 11, no. 7 (September 2017): 805–13. http://dx.doi.org/10.1049/iet-spr.2016.0351.
Повний текст джерелаДисертації з теми "Sar/spr"
Maignan, Jordany Richarlson. "Development of Orally Bioavailable 4(1H)-Quinolones and 1,2,3,4-Tetrahydroacridin-9(10H)-ones with Potent Anti-malarial Activity." Scholar Commons, 2015. http://scholarcommons.usf.edu/etd/5873.
Повний текст джерелаLe, Du Julie. "Développement d'antagonistes des récepteurs CXCR2 contre les pathologies angiogéniques oculaires et le cancer." Electronic Thesis or Diss., Université Côte d'Azur, 2024. http://www.theses.fr/2024COAZ5067.
Повний текст джерелаAngiogenesis, the process of forming new blood vessels, plays a crucial role in the progression of various cancers and ocular diseases. CXCR2 chemokine receptors are implicated in these processes by mediating cell proliferation, inflammation, and the formation of new blood vessels. This thesis aims to develop CXCR2 receptor antagonists to inhibit these pathological mechanisms, particularly pathological tumor and ocular angiogenesis. Based on previous research, we investigated new N,N'-diarylurea analogues as inhibitors of the ELR+CXCL-CXCR2 pathway for cancer treatment. Two series of analogues were synthesized to study the structure-activity relationship and to optimize a lead compound. Evaluations on renal, head and neck cancer, and uveal melanoma cell lines, as well as on 3D spheroid cultures, identified an optimized lead compound showing significant inhibition of invasion, migration, and neo-angiogenesis. Additionally, pharmacology, pharmacodynamics, and polymorphism studies were conducted.In the context of ocular angiogenic diseases, the development of a second family of compounds was pursued, including the study of new synthetic routes for scaling up for future industrial production and formulation studies to create active ingredient preparations in the form of eye drops.Finally, a new series of anticancer compounds was designed, and a synthetic route was developed to obtain a first series of analogues. The evaluation of the biological activities of these compounds allowed the establishment of a preliminary structure-activity relationship
Частини книг з теми "Sar/spr"
Sizochenko, Natalia, and Jerzy Leszczynski. "Review of Current and Emerging Approaches for Quantitative Nanostructure-Activity Relationship Modeling." In Materials Science and Engineering, 1704–21. IGI Global, 2017. http://dx.doi.org/10.4018/978-1-5225-1798-6.ch070.
Повний текст джерела